Researchers identify a major stem cell variant in lungs of patients with idiopathic pulmonary fibrosis

A pair of internationally renowned stem cell cloning experts at the University of Houston is reporting their findings of variant cells in the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF) which likely represent key targets in any future therapy for the condition.

Related Keywords

Danielle Ellis ,Frank Mckeon ,Howardj Huang ,Houston Methodist Lung Transplant Center ,University Of Houston ,Stem Cell Center ,Idiopathic Pulmonary Fibrosis ,Methodist Lung Transplant Center ,Science Translational ,Medical Director ,Houston Methodist Lung Transplant ,Fibrosis ,Lungs ,Pulmonary Fibrosis ,Iochemistry ,Breathing ,Fell ,Hronic ,Cloning ,N Vitro ,Ung Disease ,Lung Transplant ,Medicine ,Research ,Stem Cells ,Transplant ,